Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,103 INR | +1.78% | -0.69% | +1.79% |
Sales 2024 * | 287B 3.44B | Sales 2025 * | 314B 3.78B | Capitalization | 635B 7.63B |
---|---|---|---|---|---|
Net income 2024 * | 31.55B 379M | Net income 2025 * | 37.82B 454M | EV / Sales 2024 * | 2.15 x |
Net cash position 2024 * | 17.37B 209M | Net cash position 2025 * | 33.47B 402M | EV / Sales 2025 * | 1.91 x |
P/E ratio 2024 * |
20.2
x | P/E ratio 2025 * |
16.7
x | Employees | 23,451 |
Yield 2024 * |
0.38% | Yield 2025 * |
0.46% | Free-Float | 47.93% |
Latest transcript on Aurobindo Pharma
1 day | +1.48% | ||
1 week | -1.29% | ||
Current month | +1.04% | ||
1 month | +4.47% | ||
3 months | -4.41% | ||
6 months | +27.76% | ||
Current year | +1.49% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Director of Finance/CFO | - | 12-12-31 | |
B. Adi Reddy
CMP | Compliance Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Founder | 66 | 86-12-25 | |
Director/Board Member | 64 | 03-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 6 M€ | +6.07% | - | |
0.22% | 18 M€ | +2.25% | ||
0.12% | 11 M€ | +0.50% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1,103 | +1.78% | 1 642 872 |
24-04-24 | 1,084 | -0.84% | 923,839 |
24-04-23 | 1,093 | +1.58% | 1,150,312 |
24-04-22 | 1,076 | -0.99% | 1,267,744 |
24-04-19 | 1,087 | -2.46% | 1,304,443 |
Delayed Quote NSE India S.E., April 25, 2024 at 05:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.49% | 7.62B | |
+25.61% | 660B | |
+23.66% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.68% | 219B | |
-9.94% | 196B | |
+6.78% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- AUROPHARMA Stock